Tailoring modification modules of paclitaxel prodrug nanoassemblies to manipulate efficacy and tolerance
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Catalytic Processes in Materials Science · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect10.1038/nrclinonc.2016.64 ↗
2. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. Implantable nanofiber membranes with synergistic photothermal and autophagy inhibition effects for enhanced tumor therapy efficacy10.1007/s42765-023-00311-6 ↗
4. Temperature-regulating phase change fiber scaffold toward mild photothermal–chemotherapy10.1007/s42765-022-00199-8 ↗
5. Prevention of paclitaxel-induced neuropathy by formulation approach10.1016/j.jconrel.2019.04.013 ↗
6. Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects10.1016/j.msec.2019.03.002 ↗
7. Hyperbaric oxygen regulates tumor mechanics and augments Abraxane and gemcitabine antitumor effects against pancreatic ductal adenocarcinoma by inhibiting cancer-associated fibroblasts10.1016/j.nantod.2022.101458 ↗
8. Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane(R) in rodent and non-human primate models using a stable isotope tracer assay10.1016/j.biomaterials.2021.121140 ↗
9. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications10.1016/j.jconrel.2014.03.026 ↗
10. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer
11. Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency10.1021/ja513034e ↗
12. Absorption, distribution, metabolism and excretion of the biomaterials used in nanocarrier drug delivery systems10.1016/j.addr.2019.06.008 ↗
13. Engineering small molecule nanodrugs to overcome barriers for cancer therapy10.1002/VIW.20200062 ↗
14. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment10.1016/j.cclet.2022.05.032 ↗
15. Precisely engineering a dual-drug cooperative nanoassembly for proteasome inhibition-potentiated photodynamic therapy10.1016/j.cclet.2021.11.056 ↗
16. Stimulus-responsive self-assembled prodrugs in cancer therapy10.1039/D2SC01003H ↗
17. Carrier-free nanomedicines for cancer treatment10.1016/j.pmatsci.2021.100919 ↗
18. Nanoparticulation of prodrug into medicines for cancer therapy
19. Stimuli-responsive prodrug chemistries for drug delivery
20. On-demand assembly of polymeric nanoparticles for longer-blood-circulation and disassembly in tumor for boosting sonodynamic therapy
21. On-demand phototoxicity inhibition of sensitizers and H2S-triggered in-situ activation for precise therapy of colon cancer10.1016/j.nantod.2023.101863 ↗
22. NIR-II-Triggered composite nanofibers to simultaneously achieve intracranial hemostasis, killing superbug and residual cancer cells in brain tumor resection surgery10.1007/s42765-022-00210-2 ↗
23. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies
24. Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy10.1021/acs.nanolett.8b00737 ↗
25. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy10.1038/s41467-019-11193-x ↗
26. Porphyrin centered paclitaxel tetrameric prodrug nanoassemblies as tumor-selective theranostics for synergized breast cancer therapy10.1002/adhm.202202024 ↗
27. Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy10.1016/j.jconrel.2017.08.034 ↗
28. Gemcitabine lipid prodrugs: The key role of the lipid moiety on the self-assembly into nanoparticles10.1021/acs.bioconjchem.1c00051 ↗
29. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety10.1016/j.actbio.2022.12.005 ↗
30. Rational design of tumor-selective prodrug nanoassemblies: greatly improving the in vivo fate and tolerability of high-toxic cabazitaxel10.1016/j.cej.2023.141510 ↗
31. Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery10.1002/smll.202101460 ↗
32. Mechanistic understanding of the biological responses to polymeric nanoparticles10.1021/acsnano.9b10195 ↗